1Perry S, Shaw C, McGrother C, et al. Prevalence of faecal incontinence in adults aged 40 years or more living in the commtnity. Gut,2002,50:480-484.
2Hannestad YS, Rortveit G, Sandvik H, et al. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol, 2000,53 :1150-1157.
3Aggazzotti G, Pesce F, Grassi D, et al. Prevalence of urinary incontinence among institutionalized patients: a cross-sectional epidemiologic study in a midsized city in northern Italy. Urology,2000,56:245-249.
4Nakanishi N, Tatars K, Naramura H, et al. Urinary and fecal incontinence in a community-residing older population in Japan. J Am Geriatr Soc, 1997,45:215-219.
5Hampel C, Wienhold D, Benken N, et al. Definition of overactive bladder and epidemiology of urinary incontinence. Urolo, 1997,50:4-14.
6Jackson S , Donovan J ,Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol, 1996, 77: 805-812.
7Patrick DL, Martin ML, Bushnell DM, et al. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urolo, 1999, 53:71-76.
8Bates P, Bradley WE, Glen E, et al. First report on the standardisation of terminology of lower urinary tract function. urinary incontinence procedures related to the evaluation of urine storagecystometry, urethral closure pressure profile, units of measu
9Viktrup L, Lose G. The risk of stress incontinence 5 years after first delivery. Am J Obstet Gynecol,2001,185 :82-87.
10Chancellor M, Freedman S. Tolterodine: an effective and well tolerated treatment for urge incontinence and other overactive bladder symptoms. Clinical Drug Investigation, 2000,19:83-91.
